Moody’s Ratings has upgraded the long-term issuer rating of Haleon plc and its guaranteed subsidiaries to A3 from Baa1. The rating agency also upgraded the rating on Haleon’s backed senior unsecured ...

Haleon PLC closed 11.52% short of its 52-week high of £4.18, which the company reached on March 4th.

Kepler Capital analyst Karel Zoete maintained a Buy rating on Haleon PLC (HLN – Research Report) on April 8 and set a price target of p440.00.

Berenberg raised the firm’s price target on Haleon (HLN) to 460 GBp from 457 GBp and keeps a Buy rating on the shares.Stay Ahead of the Market: ...

Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth. Read more about HLNCF stock here.

(Reuters) -Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer healthcare firm at 385 pence per share, a ...

An update from Haleon PLC Sponsored ADR ( ($HLN) ) is now available. On April 9, 2025, Haleon PLC announced a significant transaction involving ...

Shares of Haleon PLC HLN slipped 7.01% to £3.57 Monday, on what proved to be an all-around rough trading session for the ...

Arrowstreet Capital Limited Partnership bought a new stake in shares of Haleon plc (NYSE:HLN – Free Report) during the fourth ...

Sei Investments Co. cut its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 1.6% during the 4th quarter, Holdings ...

Pfizer sells entire Haleon stake for $3.24 billion Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer ...

Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands and markets.